Title : Salsalate, an old, inexpensive drug with potential new indications: a review of the evidence from 3 recent studies.

Pub. Date : 2014 Jun

PMID : 25126374






2 Functional Relationships(s)
Download
Sentence
Compound Name
Protein Name
Organism
1 Salsalate belongs to the salicylate drug class, which has been shown to inhibit I-kappaB kinase, thereby inhibiting the nuclear factor-kappaB (NF-kappaB) cascade and decreasing the production of inflammatory cytokines, as well as decreasing insulin resistance. Salicylates insulin Homo sapiens
2 Recent short-term clinical trials have shown that 3 g to 4.5 g of salicylate therapy daily has the ability to lower insulin resistance and to reduce the levels of glucose, triglycerides, and free fatty acid concentrations through regulation of the I-kappaB kinase beta/NF-kappaB pathway, with few if any side effects. Salicylates insulin Homo sapiens